Your web browser doesn’t have the Flash Player v.9 plugin installed, so this Website can’t be properly viewed.
For full experience, please download the latest Flash plugin at Adobe.com.
Download Adobe Flash Player now.
Quadrivalent human papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine
Simply fill in the information below to send your friend an e-mail with information about HPV, cervical cancer, genital warts, abnormal Pap tests and GARDASIL®.
GARDASIL® is a vaccine indicated in girls and women 9-26 years of age, for the prevention of infection caused by HPV types 6, 11, 16, and 18 and the following diseases associated with these types: cervical cancer, abnormal and precancerous cervical cells, vaginal and vulvar cancers, abnormal and precancerous vaginal and vulvar cells, and genital warts.
Here's the e-mail your friend will receive:
Hi <recipient's name>,
As friends it’s important that we watch out for each other. That's why I wanted to send you a few of the many facts that I’ve learned about human papillomavirus (HPV), cervical cancer, genital warts and how to help protect yourself from them.
I hope this information is helpful, but there's more you should know about HPV and the ways you can help protect yourself. Take a look at this Website and let's talk soon!
Your friend,
<sender's name>
This service was provided by Merck & Co., Inc; however, your e-mail address was not retained by Merck.
This site is intended only for residents of Canada. This Website is for information purposes only.
®Registered Trademark of Merck & Co., Inc. Used under license.
©2009 MERCK FROSST CANADA LTD. All rights reserved.
HPV-09-CDN-84140570-WEB
GARDASIL® is a vaccine indicated in girls and women 9-26 years of age, for the prevention of infection caused by HPV types 6, 11, 16, and 18 and the following diseases associated with these types: cervical cancer, abnormal and precancerous cervical cells, vaginal and vulvar cancers, abnormal and precancerous vaginal and vulvar cells, and genital warts.
GARDASIL® helps prevent these diseases but it does not treat them. And just like all vaccines, GARDASIL® may not fully protect everyone who gets it. GARDASIL® does not protect against all types of HPV. Duration of protection over the long term has not been established. Vaccination with GARDASIL® is not recommended during pregnancy.
Like all vaccines, GARDASIL® may cause some side effects. GARDASIL® has been shown to be generally well tolerated in adults and children as young as 9 years old. The most commonly reported side effects in girls and women included pain, swelling, itching, bruising and redness where the shot was given. Fever, nausea, dizziness, headache and vomiting were also reported. Allergic reactions may occur.
Even if you get vaccinated with GARDASIL®, it is still important to continue having regular Pap tests.
Only a healthcare professional can decide if GARDASIL® is right for you or your daughter.
This site is intended only for residents of Canada. This Website is for information purposes only.
®Registered Trademark of Merck & Co., Inc. Used under license.
©2009 MERCK FROSST CANADA LTD. All rights reserved.
HPV-09-CDN-84140570-WEB